A Boulder, Colorado-based company that tracks, analyzes and reports global bioscience venture capital investment activity has released a report on 2011 trends, finding an increase in funding and deals from 2010. In Colorado, for example, six biotech companies received venture capital funding in 2011, compared to four in 2010. And the amounts invested totaled $66.1 million in 2011, compared to $45.6 million in 2010. According to OnBioVC, which prepared the report, the telemedicine and medical device sectors saw the most activity.